BCLI.OB entered into a private placement financing with gross proceeds of $3.6M from the sale and purchase price of $0.28 per share. Read more…
BCLI.OB’s intramuscular transplantation of autologous, astrocyte-like cells, NuOwn™ significantly inhibited the degeneration of Read more…
BCLI.OB recruited Adrian Harel, PhD as its new COO and acting CEO. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.